EDGAR Filing Documents for 0001437749-22-021470

Form 8-K - Current report:

SEC Accession No. 0001437749-22-021470

Filing Date

2022-08-30

Accepted

2022-08-30 08:15:18

Documents

Period of Report

2022-08-24

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	aurx20220824b_8k.htm iXBRL	8-K	30618
2	EXHIBIT 4.1	ex_416611.htm	EX-4.1	97523
3	EXHIBIT 4.2	ex_416612.htm	EX-4.2	100503
4	EXHIBIT 4.3	ex_416613.htm	EX-4.3	82548
5	EXHIBIT 10.1	ex_416614.htm	EX-10.1	144736
6	EXHIBIT 99.1	ex_417275.htm	EX-99.1	16935
11		img01.jpg	GRAPHIC	3756
	Complete submission text file	0001437749-22-021470.txt		694078

Data Files

Seq	Description	Document	Type	Size
7	XBRL TAXONOMY EXTENSION SCHEMA	noticker-20220824.xsd	EX-101.SCH	3633
8	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	noticker-20220824_def.xml	EX-101.DEF	10461
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	noticker-20220824_lab.xml	EX-101.LAB	13928
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	noticker-20220824_pre.xml	EX-101.PRE	10452
13	EXTRACTED XBRL INSTANCE DOCUMENT	aurx20220824b_8k_htm.xml	XML	2320

Mailing Address 8285 EL RIO, SUITE 150 HOUSTON TX 77054

Business Address 8285 EL RIO, SUITE 150 HOUSTON TX 77054 832-236-9060

Nuo Therapeutics, Inc. (Filer) CIK: 0001091596 (see all company filings)